Outsourced Pharma Capacity Update – Large Molecule Drug Substance
Leading CDMOs share their current available capacity - and associated capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs. Dive into the biopharmaceutical realm, where the synthesis of biologically derived APIs encompasses cell line development, fermentation, and sophisticated purification techniques. The event will feature insights into process...
